Dr Mike Tubbs
Highly qualified (BSc PhD CPhys FInstP MIoD) expert in R&D management, business improvement and investment analysis, Dr Mike Tubbs worked for decades on the 'inside' of corporate giants such as Xerox, Battelle and Lucas. Working in the research and development departments, he learnt what became the key to his investing; knowledge which gave him a unique perspective on the stock markets.
Dr Tubbs went on to create the R&D Scorecard which was presented annually to the Department of Trade & Industry and the European Commission. It was a guide for European businesses on how to improve prospects using correctly applied research and development. He has been a contributor to MoneyWeek for many years, with a particular focus on R&D-driven growth companies.
Latest articles by Dr Mike Tubbs
-
Profits in the pipeline
Features Shares in German biotech MorphoSys firm could double as the royalties start to roll in, says Mike Tubbs.
By Dr Mike Tubbs Published
Features -
The British software sector stars investors should buy now
Cover Story You might not think of the UK as a market full of promising tech stocks. But our small- and medium-sized companies are punching above their weight, says Dr Mike Tubbs.
By Dr Mike Tubbs Published
Cover Story -
A memorable day for Biogen investors
Features Biotech company Biogen’s promising treatment for the most common cause of dementia has just cleared a key hurdle.
By Dr Mike Tubbs Published
Features -
Protect your profits – buy firms with deep and wide moats
Tutorials Firms with strong brands, superior products or that exploit network effects are hard for competitors to keep up with. That means big profits for their investors. Mike Tubbs picks the best protected companies.
By Dr Mike Tubbs Published
Tutorials -
RWS: translating tech into profits
Features RWS is a “picks-and-shovels” play for the technology sector, and boasts an excellent record, says Mike Tubbs.
By Dr Mike Tubbs Published
Features -
The fledgling industries emerging from our universities
Tutorials Science and engineering departments are innovation incubators, and regularly launch companies involved in a wide range of exciting new fields. Dr Mike Tubbs explains how to invest in spin-outs.
By Dr Mike Tubbs Published
Tutorials -
How ASML is profiting from Moore’s law
Features ASML’s cutting-edge technology will capitalise on the growing demand for computer chips, says Mike Tubbs.
By Dr Mike Tubbs Published
Features -
Want to profit from a gold rush? Invest in the picks and shovels
Tutorials Investing in a booming industry can be a risky business – only a lucky few will strike gold and produce the hot products of the future. There’s a much safer way to bet on fast-growing sectors, says Dr Mike Tubbs.
By Dr Mike Tubbs Published
Tutorials -
The pharmas making pills tailored to your genes
Cover Story Reading your genome is becoming easier and cheaper. That makes it possible to figure out which medicines will work for you. Dr Mike Tubbs picks the companies best-placed to profit.
By Dr Mike Tubbs Published
Cover Story -
How to spot tomorrow’s big stocks today
Tutorials Technological advances have transformed our day-to-day lives – and made fortunes for sharp-eyed investors. But how do you spot future innovators? Dr Mike Tubbs investigates.
By Dr Mike Tubbs Published
Tutorials -
How to invest in the next big medical breakthrough
Cover Story There is currently no cure for MS, Alzheimer’s and Parkinson’s diseases but research gallops on. There will be big rewards for the first drug company to break through, says Dr Mike Tubbs.
By Dr Mike Tubbs Published
Cover Story -
How to invest in the fight against cancer
Features A new generation of anti-cancer drugs looks promising. There are four main ways to invest, with varying levels of risk. Dr Michael Tubbs explains.
By Dr Mike Tubbs Published
Features